Thomas Flaig, M.D.

Thomas Flaig, M.D.

Assistant Professor

 

Education: University of Minnesota, June 1999

 

University of Colorado Denver
School of Medicine
Division of Medical Oncology
Appointment/Referral Tel: 720-848-0300
Tel: (303) 724-3808
Fax: (303) 724-3889
e-mail: thomas.flaig@ucdenver.edu

 

Bio

Dr. Flaig completed his fellowship in 2005 at the University of Colorado Denver, denver, CO, and then he joined the faculty of the Division of Medical Oncology.

Research

Dr. Flaig is focused on translational genitourinary cancer research, with an emphasis on prostate and bladder cancer. He is a graduate of the University of Minnesota School of Medicine and completed the hematology/oncology fellowship program at the University of Colorado in 2006. The GU oncology clinic actively participates in cooperative (SWOG) and industry-sponsored clinical trials. Dr. Flaig has recently reported on a local, investigator-initiated phase I trial of silibinin in prostate cancer patients, with a follow-up NIH-sponsored silibinin biomarker study now underway. His laboratory effort is split between new prostate cancer treatment approaches using natural products and the integration of targeted therapies into the treatment of bladder cancer.

 

PUBLICATIONS:   Journal Articles in Pub Med (www.pubmed.gov)